Immune Disease Institute

The Immune Disease Institute and Children's Hospital Boston sign an affiliation agreement. Program in Cellular and Molecular Medicine is added to the Institute's title.

Theodore M. Cronin named President of the Institute

IDI occupies new space in Center for Life Sciences Boston, 3 Blackfan Circle

Glaxo-Smith-Kline and IDI form a research partnership.

Theodore M. Cronin named acting President and CEO of the Institute

The CBR Institute for Biomedical Research (CBRI) becomes the Immune Disease Institute (IDI).

John C. Baldwin, M.D. becomes President and CEO of the Institute

Frederick W. Alt, Ph.D. becomes Scientific Director of the Institute

CBRI passes the $30 million mark in annual NIH funding

Strategic plan adopted, focusing the Institute's research on immune defense and inflammation and providing the planning and fiscal framework for the next decade of breakthrough discoveries by CBRI scientists

CBR becomes The CBR Institute for Biomedical Research (CBRI)

The Harry Keefe Scholars Program endowed at CBR by Trustee Harry Keefe, Jr. to support summer internships by Boston Latin School students

CBR moves administrative offices into 350 Longwood Avenue, Boston

The Jeffrey Modell National Diagnostics Center at CBR for immunodeficiency established by the Jeffrey Modell Foundation

CBR expands into the Warren Alpert Building on the campus of Harvard Medical School

Fred S. Rosen, M.D., becomes president of CBR

The Center becomes an academic affiliate of Harvard Medical School

Merger of the Protein Foundation with the Blood Grouping Laboratory of Children's Hospital Boston, founded by Dr. Louis Diamond, to form the Center for Blood Research (CBR)

CBR moves laboratories and offices into 800 Huntington Avenue in Boston

Establishment of the Protein Foundation as an independent institution to continue basic research begun in the Harvard Medical School laboratories of Professor Edwin Cohn